Lyell Immunopharma
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell LYEL and other ETFs, options, and stocks.About LYEL
Lyell Immunopharma, Inc. operates as a holding company, which engages in the development of cell-based immunotherapies for human diseases. The company was founded by Richard D.
LYEL Key Statistics
Stock Snapshot
As of today, Lyell Immunopharma(LYEL) shares are valued at $12.70. The company's market cap stands at 296.81M, with a P/E ratio of -1.00.
On 2026-06-10, Lyell Immunopharma(LYEL) stock traded between a low of $12.17 and a high of $13.03. Shares are currently priced at $12.70, which is +4.4% above the low and -2.5% below the high.
Lyell Immunopharma(LYEL) shares are trading with a volume of 99.18K, against a daily average of 126.85K.
In the last year, Lyell Immunopharma(LYEL) shares hit a 52-week high of $45.00 and a 52-week low of $8.46.
In the last year, Lyell Immunopharma(LYEL) shares hit a 52-week high of $45.00 and a 52-week low of $8.46.
LYEL News
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the right price. For example, although Amazon....
...
Lyell Immunopharma (LYEL) provided an update on the safety profile of LYL273 in its ongoing U.S. Phase 1 clinical trial in patients with relapsed or refractory...
Analyst ratings
83%
of 6 ratingsMore LYEL News
A downtrend has been apparent in Lyell Immunopharma (LYEL) lately with too much selling pressure. The stock has declined 39.7% over the past four weeks. However...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.